Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / June / Why Rapid Tests Fail to Gain Traction
Technology and innovation Insights Infectious Disease

Why Rapid Tests Fail to Gain Traction

Researchers identify key factors affecting the adoption and long-term use of rapid diagnostic tests across sub-Saharan Africa

06/24/2026 News 2 min read
  • Full Article
  • Summary
  • Listen
  • Scorecard
  • Quiz
  • Top Institutions
  • Topic Commentary

Share

Objective:

To analyze factors influencing the adoption and long-term use of rapid diagnostic tests (RDTs) for febrile illnesses in sub-Saharan Africa.

Approach:
  • Systematic Review: The review analyzed 48 publications from 33 countries, including 37 primary studies and 11 systematic reviews.
Key Findings:
  • Identified 436 implementation factors: 321 barriers and 115 facilitators grouped into 35 themes.
  • Common barriers included stockouts of test kits, poor integration into workflows, insufficient training, increased workload, and lack of confidence in test results.
  • Challenges with single-disease testing programs were noted, particularly with malaria RDTs leading to limited diagnostic options.
  • Facilitators for RDT uptake included simple test design, rapid turnaround times, regular training, reliable supply chains, and early testing in patient journeys.
  • Organizational factors such as stockouts, maintenance issues, and unclear responsibilities were critical for sustained use.
Interpretation:

Successful diagnostic implementation requires attention to workflow, training, infrastructure, supply management, and clinical integration.

Limitations:
  • Lack of evidence on sustaining RDT programs after initial rollout.
  • Most studies focused on adoption rather than long-term use.
Conclusion:

Future fever-management strategies may benefit from integrated diagnostic approaches addressing multiple causes of fever.

Sources:
  • Nature Communications

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Breathing New Life into Diagnostics
Technology and innovation
Breathing New Life into Diagnostics

January 22, 2024

6 min read

Jonathan Edgeworth on how metagenomics could transform testing for respiratory infections

Opening a Window into Brain Trauma
Technology and innovation
Opening a Window into Brain Trauma

January 18, 2024

4 min read

Raman spectroscopy shows promise as the first point-of-care diagnostic device for TBI

Molecular Spectacular
Technology and innovation
Molecular Spectacular

January 8, 2024

1 min read

A look at last year’s most interesting molecular pathology stories

Cracking Colon Cancer
Technology and innovation
Cracking Colon Cancer

January 25, 2024

1 min read

How a new clinically approved AI-based tool enables rapid microsatellite instability detection

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.